Nanus DM - Search Results

1

Clinical features of neuroendocrine prostate cancer.

Conteduca V, Oromendia C, Eng KW, Bareja R, Sigouros M, Molina A, Faltas BM, Sboner A, Mosquera JM, Elemento O, Nanus DM, Tagawa ST, Ballman KV, Beltran H. Conteduca V, et al. Among authors: nanus dm. Eur J Cancer. 2019 Nov;121:7-18. doi: 10.1016/j.ejca.2019.08.011. Epub 2019 Sep 13. Eur J Cancer. 2019. PMID: 31525487 Free PMC article.

2

Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens.

Guo X, Knudsen BS, Peehl DM, Ruiz A, Bok D, Rando RR, Rhim JS, Nanus DM, Gudas LJ. Guo X, et al. Among authors: nanus dm. Cancer Res. 2002 Mar 15;62(6):1654-61. Cancer Res. 2002. PMID: 11912136

3

Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.

Goldberg JS, Vargas M, Rosmarin AS, Milowsky MI, Papanicoloau N, Gudas LJ, Shelton G, Feit K, Petrylak D, Nanus DM. Goldberg JS, et al. Among authors: nanus dm. Cancer. 2002 Sep 15;95(6):1220-7. doi: 10.1002/cncr.10809. Cancer. 2002. PMID: 12216088 Free article. Clinical Trial.

4

High expression of the Met receptor in prostate cancer metastasis to bone.

Knudsen BS, Gmyrek GA, Inra J, Scherr DS, Vaughan ED, Nanus DM, Kattan MW, Gerald WL, Vande Woude GF. Knudsen BS, et al. Among authors: nanus dm. Urology. 2002 Dec;60(6):1113-7. doi: 10.1016/s0090-4295(02)01954-4. Urology. 2002. PMID: 12475693

5

Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma.

Nanus DM, Garino A, Milowsky MI, Larkin M, Dutcher JP. Nanus DM, et al. Cancer. 2004 Oct 1;101(7):1545-51. doi: 10.1002/cncr.20541. Cancer. 2004. PMID: 15378501 Free article.

6

Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.

David KA, Milowsky MI, Kostakoglu L, Vallabhajosula S, Goldsmith SJ, Nanus DM, Bander NH. David KA, et al. Among authors: nanus dm. Clin Genitourin Cancer. 2006 Mar;4(4):249-56. doi: 10.3816/CGC.2006.n.003. Clin Genitourin Cancer. 2006. PMID: 16729907 Review.

7

Chemotherapy for non-clear-cell renal cell carcinoma.

David KA, Milowsky MI, Nanus DM. David KA, et al. Among authors: nanus dm. Clin Genitourin Cancer. 2006 Mar;4(4):263-8. doi: 10.3816/CGC.2006.n.005. Clin Genitourin Cancer. 2006. PMID: 16729909 Review.

8

Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.

Osman I, Dai J, Mikhail M, Navarro D, Taneja SS, Lee P, Christos P, Shen R, Nanus DM. Osman I, et al. Among authors: nanus dm. Cancer. 2006 Dec 1;107(11):2628-36. doi: 10.1002/cncr.22312. Cancer. 2006. PMID: 17083125 Free article.

9

Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.

Tewari A, Divine G, Chang P, Shemtov MM, Milowsky M, Nanus D, Menon M. Tewari A, et al. J Urol. 2007 Mar;177(3):911-5. doi: 10.1016/j.juro.2006.10.040. J Urol. 2007. PMID: 17296374

10

Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.

David KA, Mallin K, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. David KA, et al. Among authors: nanus dm. Cancer. 2009 Apr 1;115(7):1435-47. doi: 10.1002/cncr.24147. Cancer. 2009. PMID: 19215030 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page